Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > AGN as National Inflation Association's #1 stock
View:
Post by waves1 on Aug 25, 2022 1:55pm

AGN as National Inflation Association's #1 stock

National Inflation Association announced Algernon Pharmaceuticals ($AGN.c $AGNPF)  as its #1 favorite biotechnology stock suggestion! 
 
NIA highlighted that AGN's largest shareholder is Alpha North Asset Management who increased its stake in AGN to 13% earlier this week and that AGN is preparing to launch a Phase I study of DMT for the treatment of stroke.
 
Alpha North increased its stake following the recent share price weakness as it provided a great opportunity to increase its position with CEO Steve Palmer stating "Our increased investment confirms our support for the drug pipeline they are developing as well as our strong belief in management"
 
https://inflation.us/content/nias-1-favorite-biotech-stock-suggestion-agn
Be the first to comment on this post
Algernon Pharmaceuticals Inc.